Ibogaine shares receptor effects with both Salvia divinorum (κ-opiate down-regulation of tolerance via beta-arrestin) and with ketamine (NMDA antagonism, curbing narcotic withdrawal and super-sensitization to stimulants). Additionally, ibogaine induces the nerve growth factor GDNF (Glia-Derived Neurotrophic Factor), re-sprouting chronically desensitised dopamine receptors and replacing the neural deficit experienced as craving. Moreover, the 10-fold GDNF spike engendered by ibogaine back-signals to cell nuclei to make more GDNF, setting up ...
Interview with Ibogaine Adviser
Ibogaine Treatment – Interview with Ibogaine Adviser Patrick Venulejo. Learn what is ibogaine & various types being used, what to expect and not expect from it, what are the indications, etc.
To watch the full 45 min. inteview, subscribe at: www.ibogainetreatment.net
source
Ibogaine influence on gene expression – Roman Paskulin
Tabernanthe iboga with its alkaloid ibogaine is recognized in the West as a remedy against diverse addictions, while traditionally it is used as inductor of maturation. Its uniqueness lays in the multiple actions – it triggers psychedelic insights, facilitates metabolic adaptations and sets new ...
Amanda Feilding: From Taboo to Treatment: The Coming of Age of Psychedelic Medicine
Learn more and donate: http://www.maps.org/
Amanda Feilding: From Taboo to Treatment – The Evolution of Psychedelic Medicine
2017 Psychedelic Science Conference
http://psychedelicscience.org/
A six-day global gathering of the international scientific community in Oakland, California to explore new research into the benefits and risks of MDMA, LSD, psilocybin, ayahuasca, ketamine, ibogaine, medical marijuana, and more.
source
Panel: Insights from Contemporary Ibogaine Addiction Research w/ Noller & Brown
Learn more and donate: http://www.maps.org/
PANEL:
Geoff Noller, PhD, and Thomas Kingsley Brown, PhD
moderated by Clare Wilkins
Insights from Contemporary
Ibogaine Research for Addiction
2017 Psychedelic Science Conference
http://psychedelicscience.org/
A six-day global gathering of the international scientific community in Oakland, California to explore new research into the benefits and risks of MDMA, LSD, psilocybin, ayahuasca, ketamine, ibogaine, medical marijuana, and more.
source